The Daily StarOpinion

The danger of antibiotic resistance must not be ignored anymore

These troubling trends indicate that the five-year National Strategy and Action Plan for Antimicrobial Resistance Containment ...
Le Lézard

Canada's $1.5-billion Rare Disease Drug Strategy generating 'return on investment' for patients and society but more needs to be done

National Strategy for Drugs for Rare Diseases, the Canadian Organization for Rare Disorders (CORD) is pleased to report that children and adults living with nine different ...
Sampson IndependentOpinion

Dipping into a writer’s inkwell

What began as a quaint little story about a hospital chief of staff — Dr. John Rutledge — and his idyllic family, blossomed ...

Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS

Publication details large multicenter clinical trial demonstrating significant reductions in IBS symptoms through inFoods IBS guided dietary ...